FDG and Beyond

Dirk de Ruysscher, Karin Haustermans, Daniela Thorwarth

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic


Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.
Original languageEnglish
Title of host publicationMolecular Radio-Oncology
EditorsMichael Baumann, Mechthild Krause, Nils Cordes
ISBN (Electronic)978-3-662-49651-0
ISBN (Print)978-3-662-49649-7
Publication statusPublished - 2016

Publication series

SeriesRecent Results in Cancer Research

Cite this